Ongentys and Kynmobi Will Be New Meds for Parkinson's Disease

December 2020

Ongentys (opicapone) and Kynmobi (apomorphine) will be added to the growing roster of meds for Parkinson's disease.

They're for "off" episodes...when symptoms (tremor, etc) return between carbidopa/levodopa doses, especially as Parkinson's progresses.

Anticipate that these meds will be saved for when dose adjustments of carbidopa/levodopa don't help...or other add-ons (pramipexole, rasagiline, etc) aren't enough or aren't tolerated.

Practical advice for a better career, with unlimited access to CE

Hospital Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Med Histories Help Inpatients Get Needed Vaccines
Med Safety Watch for New Concentrations of IV Ephedrine and Phenylephrine
IV Medications Take Steps to Ensure Safety With IV Boluses and Loading Doses
Hemorrhage Think of Sevenfact as Similar to NovoSeven RT
Diabetes Meds Expect to See SGLT2 Inhibitors for Some Patients WithOUT Diabetes
Parkinson's Disease Ongentys and Kynmobi Will Be New Meds for Parkinson's Disease
Alcohol Know How Hangover Remedies Stack Up
Contraceptives Twirla Will Be Similar to Xulane for Contraception
Multiple Sclerosis Be Familiar With the Latest Multiple Sclerosis Meds

Ongentys and Kynmobi Will Be New Meds for Parkinson's Disease

Practical advice for a better career, with unlimited access to CE

Table of Contents